TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.550
+0.210 (6.29%)
At close: Jun 10, 2026, 4:00 PM EDT
3.420
-0.130 (-3.66%)
After-hours: Jun 10, 2026, 4:57 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $218.03 million as of June 10, 2026. Its market cap has increased by 3.63% in one year.
Market Cap
218.03M
Enterprise Value
188.59M
1-Year Change
3.63%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $218.03M, a decrease of -33.68%. That is a compound annual growth rate of -7.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 205.13M | -41.18% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sight Sciences | 263.89M |
| Profound Medical | 248.97M |
| Treace Medical Concepts | 241.98M |
| Quantum-Si incorporated | 214.95M |
| Apyx Medical | 203.51M |
| RxSight | 203.26M |
| Lucid Diagnostics | 188.77M |
| InfuSystem Holdings | 181.84M |